RxBiologics

RxBiologics is a Cambridge-based antibody discovery CRO and subsidiary of RxCelerate.

Its proprietary phage display library platform incorporates in-line optimisation technology modelled on B cell affinity maturation, designed to generate clinic-ready antibody candidates with drug-like properties from first selection.

Services include antibody discovery, antigen optimisation, expression and purification, developability screening, and characterisation, supporting client programmes from early discovery through preclinical phases.